BMJ
UK Randomised Controlled Trial Registration Project, UK Cochrane Centre, Oxford OX2 7LG.
Published: November 2003
Objectives: To describe the characteristics of randomised controlled trials supported by the main non-commercial sources of funding in the United Kingdom between 1980 and 2002.
Design: Descriptive survey.
Setting: Randomised controlled trials funded by the Medical Research Council, NHS research and development programme, Department of Health, Chief Scientist Office in Scotland, and medical research charities.
Participants: 1464 randomised controlled trials supported by the main non-commercial sources of funding.
Results: Support for randomised controlled trials by the main sources of non-commercial funding in the United Kingdom has fallen in recent years, without any concomitant increase in the sample sizes of these studies. Drug trials in a limited range of health problems have dominated among the studies supported by the Medical Research Council and medical research charities. Until recently, the NHS research and development programme supported randomised controlled trials of various healthcare interventions, in a wide range of health problems, but between 1999 and 2002 many of the subprogrammes that had commissioned trials were discontinued.
Conclusions: The future of non-commercial randomised controlled trials in the United Kingdom has been threatened by the discontinuation or demise of national and regional NHS research and development programmes. Support also seems to be declining from the Medical Research Council and the medical research charities. It is unclear what the future holds for randomised controlled trials that address issues of no interest to industry but are of great importance to patients and practitioners.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC261654 | PMC |
http://dx.doi.org/10.1136/bmj.327.7422.1017 | DOI Listing |
Ann Am Thorac Soc
March 2025
University Hospital of Zurich, Heart Vessel Thorax, Zurich, Switzerland;
Background: Patients with pulmonary vascular disease (PVD) often reveal nocturnal hypoxemia and sleep apnea. We investigated whether exposure to high altitude worsens those conditions.
Methods: In a randomized-controlled crossover trial, stable patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) without resting hypoxemia (PaO2 >8 kPa at low altitude) underwent respiratory polygraphy at 470 m and during an overnight stay at 2500 m.
Ophthalmic Surg Lasers Imaging Retina
March 2025
The aim of this review is to provide an overview of the literature on dropless vitreoretinal surgery. A comprehensive search was conducted using the PubMed database from August 2004 to August 2024 using the following keywords: "dropless" and "vitrectomy" or "retinal surgery" or "detachment surgery". Relevant studies included randomized controlled trials (RCTs) and observational studies.
View Article and Find Full Text PDFPain
March 2025
Child Health Evaluative Sciences Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Pain is the hallmark symptom of sickle cell disease (SCD). By adolescence, 20% of youth with SCD develop chronic SCD pain. Our randomized controlled trial found significant reductions in pain in youth receiving digital cognitive-behavioral therapy (CBT) vs education control.
View Article and Find Full Text PDFRheumatology (Oxford)
March 2025
Mayo Clinic Evidence-based Practice Center, Mayo Clinic, Rochester, MN, USA.
Objectives: Inclusion body myositis (IBM) is characterized by slowly progressive muscle weakness making it challenging to detect weakness changes during a clinical trial. Trial participants receiving placebo may behave differently than in natural history studies. We aimed to quantify the decline in muscle strength and IBM functional rating scale (IBMFRS) of IBM patients receiving placebo during clinical trials.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.